Veracyte | VCYT - Créances Commerciales

Prix De L'Action
32.67
Variation Quotidienne
0.89 2.80%
Mensuellement
1.43%
Annuel
9.96%
Q2 Prévisions
33.60




Créances Commerciales Changement Date
Agenus USD 22.44M 1.14M 2025-12
Agilent USD 1.52B 34M 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Bruker USD 544.9M 6M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Illumina USD 854M 125M 2025-12
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Laboratory Of America USD 2.26B 4.5M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Myriad Genetics USD 115.3M 2.7M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Siemens EUR 26.81B 500M 2025-12
Sonic Healthcare AUD 1.39B 23.76M 2024-12
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Veracyte USD 44.66M 3.17M 2025-12
Waters USD 828.84M 80.32M 2025-12